What EUR.IM.EX. PHARMA. does

Eurimex Pharma SAS is a French independent pharmaceutical logistics and wholesale distribution company serving French, European, and foreign pharmaceutical laboratories seeking export access to French-speaking sub-Saharan Africa and French overseas territories (DOM-TOM). The company is structured as a Société par Actions Simplifiées with €160,000 of released capital and operates from Etrelles with warehousing facilities in Vitré on the Rennes-Paris highway axis. It holds dual regulatory statuses: a licensed pharmaceutical establishment (établissement pharmaceutique) for depositary and wholesale distribution activities for export, and a customs warehouse (entrepôt sous douane). Its 1,050 m² warehousing platform supports a 900-pallet storage capacity.

The company's core service offering spans pharmaceutical distribution, storage and warehousing, visa registration with relevant ministries, logistics coordination, and ancillary marketing support including connections to medical promotion agencies in French-speaking Africa, storage and shipping of promotional materials and free medical samples, and design of market-adapted promotional materials. It is explicitly positioned as an independent intermediary, unaffiliated with any international laboratory subsidiary or purchasing office, which enables it to serve all client categories — subsidiary wholesalers, purchasing office wholesalers, and independent wholesalers — across both private and public markets. Pricing is based on the PGHT (Prix Grossiste Hors Taxes) wholesale price benchmark obtained from the Direction des Pharmacies et du Médicaments at the French Ministry of Health, and deliveries are made on Incoterm DDU (tax duties not included) from its French warehouses.

The go-to-market is sales-led and B2B, with direct engagement between Eurimex Pharma's small team (6 employees) and pharmaceutical laboratory clients. Geographic reach is concentrated on three pillars: mainland France, French-speaking sub-Saharan Africa, and named DOM-TOM territories (Guyana, Guadeloupe, La Réunion, Martinique, Madagascar, Djibouti). The revenue model is transaction-based, with fees derived from the wholesale distribution of pharmaceutical products intended for human medicine. No revenue figures, funding rounds, M&A activity, or leadership changes are disclosed in the available data.

Name

EUR.IM.EX. PHARMA.

Legal name

Eurimex Pharma SAS

Website

https://eurimex-pharma.fr

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Eurimex Pharma is an independent French pharmaceutical logistics and wholesale distributor that helps French, European, and foreign laboratories export medicines to French-speaking sub-Saharan Africa and French overseas territories via a customs warehouse and licensed pharmaceutical establishment.

Ownership category

akta.pro rank

Headquarters

HQ city

Vitré

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution Services: Eurimex Pharma generates revenue through wholesale distribution of pharmaceutical products to laboratories, providing logistics, storage, and export services. Pricing is based on the PGHT (Prix Grossiste Hors Taxes - Wholesale Price Before Tax) obtained from the DPM (Direction des Pharmacies et du Médicaments) at the Ministry of Health. The company operates as a customs warehouse and pharmaceutical establishment for depositary and wholesale distribution activities for export.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Eurimex Pharma provides wholesale pharmaceutical distribution, customs-bonded warehousing (entrepôt sous douane), and depositary services for human-use medicines on behalf of French, European, and foreign pharmaceutical laboratories. The company offers an integrated bundle of logistics, regulatory visa registration with relevant ministries, and marketing support, including connections to medical promotion agencies, free storage of promotional materials, shipment of free medical samples to medical representatives, and design of market-adapted promotional materials. Operations target export markets in French-speaking sub-Saharan Africa, French overseas territories (DOM-TOM), and France from a 1,050 m², 900-pallet warehouse located in Vitré, France.

Product overview

Eurimex Pharma operates as a unified pharmaceutical logistics platform offering integrated services to pharmaceutical laboratories. The core offerings include customs warehouse storage (1,050 m² facility in Vitré with 900 pallet capacity) and wholesale distribution services for medications intended for human medicine. These core services are supported by ancillary offerings: visa registration services with relevant ministries, logistics and marketing services including connections to medical promotion agencies in French-speaking Africa, storage and shipment of promotional materials and free medical samples, and promotional material design services adapted for the African market. The company serves laboratories across French-speaking Africa, DOM-TOM territories, and France.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Distribution Services

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Eurapharma: Subsidiary of Pierre Fabre and one of the largest pharmaceutical distributors in sub-Saharan Africa. Directly comparable to Eurimex as a France-based wholesaler shipping medicines into Francophone African markets, though at much larger scale.
• Biogaran: French generic pharmaceutical manufacturer that also exports into Francophone Africa. Comparable as a France-based pharmaceutical exporter navigating the same regulatory and logistics corridor Eurimex services.
• Medipha Santé: French pharmaceutical wholesaler and exporter with operations in Francophone Africa and the Indian Ocean. Comparable as a France-based wholesale distributor with focus on African markets.
• OCP République (Office Commercial Pharmaceutique): French pharmaceutical wholesaler (historically part of the CERP cooperative) distributing to French and African customers. Comparable as a wholesaler with French pharmaceutical establishment status and African export focus.
• UbiPharm: African pharmaceutical distributor headquartered in France, operating in multiple Francophone African countries. Direct comparable in the wholesale export corridor between French laboratories and sub-Saharan Africa.
• Tridem Pharma: French pharmaceutical wholesaler and exporter focused on emerging markets including Africa and Asia. Comparable as a France-based wholesale distributor with import/export and regulatory registration services.
• CERP Rhin-Rhône Méditerranée: French pharmaceutical distribution cooperative serving wholesalers and pharmacies across France and exporting to Africa. Comparable as a wholesale distributor with French regulatory standing and reach into Francophone Africa.

Broad incumbents

• Alliance Healthcare: European pharmaceutical wholesaler and pharmacy retailer (Walgreens Boots Alliance subsidiary). Overlaps with Eurimex in France-based wholesale distribution to pharmacies and healthcare providers.
• McKesson Europe: European arm of global pharmaceutical distributor McKesson, operating in France via Laphal and other banners. Broad incumbent with regulated wholesaler status across the same geography.
• Phoenix Group: Pan-European pharmaceutical wholesale leader (with PharmaLex and Alliance Healthcare retail). Comparable as a regulated pharma wholesaler, though multinational and far larger than Eurimex, with overlapping interest in Africa via subsidiaries.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Customer concentration

• LinkedInlinkedin.com/company/eur.im.ex.-pharma.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EUR.IM.EX. PHARMA.